Tandem Diabetes Care achieves record Q1 2025 sales with 22% growth, launches Control-IQ+ for type 2 diabetes, doubling its market potential.

I am a 71-year-old male with Type 2 diabetes. My last A1C test showed a value of 7.8%. I have been taking Mounjaro weekly, which lowered my ...

Are you in the gray zone? Millions are living with prediabetes, unaware of the crucial difference between it and full-blown type 2 diabetes. Let’s ...

Eli Lilly (NYSE: LLY) stock jumped over 14% on Thursday, powered by highly promising Phase 3 results for orforglipron, an ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

Eli Lilly's (LLY) stock surges 14% as its diabetes drug orforglipron meets Phase 3 goals, cutting weight by 8%. Read more ...

Understanding your health requires more than just regular checkups and occasional blood tests. One of the most critical markers of overall well-being, especially for those at risk of or living with ...

While medical evidence doesn’t support essential oils for treating diabetes, there’s some evidence that suggests they can potentially help with certain symptoms and side effects. Essential ...

Summer's heat poses unique challenges for individuals with diabetes, impacting blood sugar control and insulin effectiveness. Staying hydrated, frequently monitoring blood sugar, and properly ...

Bridge is a desktop application that allows you to search for and download charts that can be played in games like Clone Hero, YARG, etc ...

Type 2 diabetes also puts you at risk for certain health conditions that can reduce life expectancy. Type 2 diabetes typically shows up later in life, although the incidence in younger people is ...

In a 26-week Type 2 Diabetes study, icovamenib demonstrated a statistically significant reduction in A1C levels compared to placebo in insulin-deficient patients. Moreover, the drug exhibited an ...